Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges.
Saved in:
| Title: | Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges. |
|---|---|
| Authors: | Debellut F; Center for Vaccine Innovation and Access, PATH, Geneva, Switzerland., Constenla D; Independent Consultant, Climawahealth, Ellicott City, MD, USA., Mvundura M; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Hausdorff WP; Center for Vaccine Innovation and Access, PATH, Washington, DC, USA; Universite Libre de Bruxelles, Brussels, Belgium., Hasso-Agopsowicz M; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Jit M; Department of Global and Environmental Health, School of Global Public Health, New York University, New York, NY, USA., Portnoy A; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA., Aggarwal R; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India., Sheel M; School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Davies NG; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK., Sim SY; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Lambach P; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Postma M; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia; Faculty of Economics & Business, University of Groningen, Groningen, the Netherlands; Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia., Gill C; Global Health/Integrated Clinical Vaccine Development, Gates Foundation, Seattle, WA, USA., Giersing B; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland., Pecenka C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA. Electronic address: cpecenka@path.org. |
| Source: | Vaccine [Vaccine] 2026 Apr 30; Vol. 80, pp. 128561. Date of Electronic Publication: 2026 Apr 07. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41950850 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Debellut+F%22">Debellut F</searchLink>; Center for Vaccine Innovation and Access, PATH, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Constenla+D%22">Constenla D</searchLink>; Independent Consultant, Climawahealth, Ellicott City, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mvundura+M%22">Mvundura M</searchLink>; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Hausdorff+WP%22">Hausdorff WP</searchLink>; Center for Vaccine Innovation and Access, PATH, Washington, DC, USA; Universite Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Hasso-Agopsowicz+M%22">Hasso-Agopsowicz M</searchLink>; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jit+M%22">Jit M</searchLink>; Department of Global and Environmental Health, School of Global Public Health, New York University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Portnoy+A%22">Portnoy A</searchLink>; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aggarwal+R%22">Aggarwal R</searchLink>; Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.<br /><searchLink fieldCode="AU" term="%22Sheel+M%22">Sheel M</searchLink>; School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Davies+NG%22">Davies NG</searchLink>; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Sim+SY%22">Sim SY</searchLink>; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lambach+P%22">Lambach P</searchLink>; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Postma+M%22">Postma M</searchLink>; Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia; Faculty of Economics & Business, University of Groningen, Groningen, the Netherlands; Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.<br /><searchLink fieldCode="AU" term="%22Gill+C%22">Gill C</searchLink>; Global Health/Integrated Clinical Vaccine Development, Gates Foundation, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Giersing+B%22">Giersing B</searchLink>; Department of Immunization, Vaccines & Biologicals, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pecenka+C%22">Pecenka C</searchLink>; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA. Electronic address: cpecenka@path.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Apr 30; Vol. 80, pp. 128561. <i>Date of Electronic Publication: </i>2026 Apr 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41950850 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2026.128561 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 128561 Titles: – TitleFull: Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Debellut F – PersonEntity: Name: NameFull: Constenla D – PersonEntity: Name: NameFull: Mvundura M – PersonEntity: Name: NameFull: Hausdorff WP – PersonEntity: Name: NameFull: Hasso-Agopsowicz M – PersonEntity: Name: NameFull: Jit M – PersonEntity: Name: NameFull: Portnoy A – PersonEntity: Name: NameFull: Aggarwal R – PersonEntity: Name: NameFull: Sheel M – PersonEntity: Name: NameFull: Davies NG – PersonEntity: Name: NameFull: Sim SY – PersonEntity: Name: NameFull: Lambach P – PersonEntity: Name: NameFull: Postma M – PersonEntity: Name: NameFull: Gill C – PersonEntity: Name: NameFull: Giersing B – PersonEntity: Name: NameFull: Pecenka C IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 04 Text: 2026 Apr 30 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 80 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |